Currently the protein mutant database (PMD) contains over 81 000 mutants, including artificial as well as natural mutants of various proteins extracted from about 10 000 articles. We recently developed a powerful viewing and retrieving system (http://pmd.ddbj.nig.ac.jp ), which is integrated with the sequence and tertiary structure databases. The system has the following features: (i) mutated sequences are displayed after being automatically generated from the information described in the entry together with the sequence data of wild-type proteins integrated. This is a convenient feature because it allows one to see the position of altered amino acids (shown in a different color) in the entire sequence of a wild-type protein; (ii) for those proteins whose 3D structures have been experimentally determined, a 3D structure is displayed to show mutation sites in a different color; (iii) a sequence homology search against PMD can be carried out with any query sequence; (iv) a summary of mutations of homologous sequences can be displayed, which shows all the mutations at a certain site of a protein, recorded throughout the PMD.
INTRODUCTION
Protein mutant database (PMD) is a compilation of protein mutant data, providing information on functional and/or structural influences brought about by amino acid mutations at specific positions of a protein (1) . Among other mutant databases, PMD is unique in two respects: (i) almost all proteins are included, except for natural mutants of the globin and immunoglobulin families; (ii) natural as well as artificial mutants are covered, including random and site-directed mutants. PMD data have been extracted from literature published in the 1970s up to the middle of 1995. More than 10 000 articles are now recorded, comprising about 81 000 protein mutants. When the project started in 1989, database construction, i.e., reading articles, extracting necessary information and keying-in the data, was carried out at the Protein Engineering Research Institute in Osaka. Since April 1997, all the tasks have been moved to the National Institute of Genetics in Mishima. Table 1 summarizes proteins categorized by the PIR superfamilies that most frequently appeared in PMD, showing how various proteins are contained in our database.
DESCRIPTION
The data complied in PMD are based on published literature, not on proteins. That is, each entry in the database corresponds to one article, which may contain several or a number of protein mutants. Each database entry is identified by a serial number and is defined as either natural or artificial, depending on the type of the mutation. For each entry the following items are recorded: 'JOURNAL'; 'TITLE'; 'CROSS-REFERENCE'; 'PROTEIN'; 'N-TER-MINAL'; 'CHANGE'; 'FUNCTION'; 'STRUCTURE'; 'STA-BILITY'; etc. 'CROSS-REFERENCE' indicates the code names of the protein given in other databases, such as, Protein Identification Resources (2) . 'N-TERMINAL' shows the N-terminal five amino acids of sequence, which may help to show the unambiguous numbering of the sequence. As the full sequence is usually not shown in a paper, mutated and original amino acid residues, with their position numbers allocated in the paper, are checked against the PIR, to confirm the starting five residues at the N terminus. 'CHANGE' indicates the position and kind of mutation, such as amino acid substitution, insertion and deletion. Each mutation is denoted with a specific notation. Any functional or structural features ('FUNCTION', 'STRUCTURE', 'STABILITY', etc.) observed in the mutant are described immediately after 'CHANGE'. Relative differences in activity and/or stability, in comparison with the wild-type protein, are indicated with symbols Since 1997, we have extended the 'CHANGE' description in two ways: (i) type of operation is added to the header 'CHANGE', for example, 'CHANGE-POINT' stands for point mutation, 'CHANGE-DELETE' for sequence deletion; (ii)'CHANGE-CHIMERA' indicates a chimeric protein. In this case, the entire sequence of the chimera is explicitly shown, as it is difficult to describe the sequence by operational words. Details of the description are shown in our web page (http://pmd.ddbj.nig.ac.jp ).
VIEWING AND RETRIEVING THE SYSTEM
Recently, we developed the powerful viewing and retrieving system of PMD, which is integrated with the sequence database, PIR (2), the tertiary structure database, PDB (3), and has world wide web interface (http://pmd.ddbj.nig.ac.jp ). The relationship between the three databases is schematically shown in Figure 1 . This system has the following features.
Show mutated sequences
The PMD entry only records information on altered sequences in operational words, such as 'Cys 117 Ser' or 'Ser-Ala 84-94 AWEKDL' (Fig. 2a) . These brief descriptions are sufficient as minimum information, but it is sometimes difficult to know the complete sequence of the mutant protein. Therefore, we have developed a program that generates a mutant sequence from change operations in PMD and the corresponding wild-type sequence retrieved from PIR database. Changed regions are shown in a different color. A sample of generated sequences is shown in Figure 2b .
Show 3D structure
If a tertiary structure of a wild-type sequence is experimentally determined, the 3D structure is displayed to show mutation sites in a different color. The sequence is linked with any one of the 3D structures in PDB with more than 50% sequence identity. A structure is shown in a C α wire-frame model, and the mutated sites are displayed in yellow. Various color schemes to highlight secondary structures or solvent accessible surface (6) are available. A sample of the 3D structure view is shown in Figure 2c .
Sequence homology search
A sequence homology search against the PMD database can be carried out with any query sequence, pasted on the input area of our web page. Using this function, it is easy to find entries that have related sequences. The search is performed against the wild-type, but not against mutated sequences. The program for sequence homology search was written by one of the authors (T.K.). The algorithm was based on the standard alignment technique (4) and the ktup filtering (5). The user can choose a threshold value of sequence identity between 30 and 100%. A result of the search is displayed as a multiple alignment of wild-type sequences, whose mutated sites are differently colored. A sample of the result is shown in Figure 3a .
Summary of mutants at a certain site
By clicking a site of the sequence homology search result, a summary of mutants at the site can be generated from all related PMD entries. An example is shown in Figure 3b . This function is convenient because it allows the user to find active sites or structurally important sites.
FUTURE DIRECTION
As the amount of literature concerning mutant proteins increases every year, the task of constructing the database is becoming more difficult. We are currently about three years behind, dealing with articles published in 1995. One way to overcome this problem, is to limit proteins that should be reviewed. We are now planning to deal primarily with those proteins of known structure, in order to cut down the number of articles to be handled. This would reduce the amount of data to one third. Another problem is the complexity of mutation data. In the early stages of the sitedirected mutagenesis technique, simple amino acid substitutions were the main form of protein mutations. At this time, however, more complicated and/or larger scaled mutations have frequently been incorporated into natural proteins, and even de novo designed proteins are synthesized. This trend results in the technical difficulty of expressing alterations in a mutant protein in comparison with the wild-type protein. In addition, the concept of mutant proteins itself is becoming relatively obscure, for example, de novo proteins. De novo designed proteins, to which the wild-types cannot uniquely be defined, are excluded since the standard for a mutant in PMD is to be described relative to a natural protein. On the same principle, mutations introduced into chimeric proteins are excluded, although simple chimera made of two natural proteins are included.
